The Beauty Health Company (SKIN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.55M | 15.2M | 9.65M | 9.65M | 3M | 16.47M | 10.31M | 6.2M | -16.85M | -5.17M | 17.96M | 21.97M |
| Operating CF Margin % | -8.56% | 18.45% | 13.65% | 12.34% | 4.31% | 19.73% | 13.09% | 6.84% | -20.7% | -5.34% | 18.44% | 18.7% |
| Operating CF Growth % | -285.38% | -7.75% | -6.48% | 55.56% | 117.78% | 418.61% | -42.58% | -71.77% | -29.55% | 4.13% | 157.21% | 170.1% |
| Net Income | -6.6M | -8.1M | -11.03M | 19.71M | -10.1M | -10.33M | -18.29M | 202K | -679K | -9.4M | -73.82M | 3.36M |
| Depreciation & Amortization | 0 | 5.35M | 9.41M | 2.83M | 6.16M | 6.56M | 1.07M | 8.92M | 8.65M | 9.9M | 7.99M | 9.9M |
| Stock-Based Compensation | 0 | 3.58M | 2.46M | 5.31M | 3.48M | 5.85M | 7.71M | 6.5M | 6.64M | 2.26M | 8.19M | 0 |
| Deferred Taxes | 0 | -674K | 0 | 1.08M | -265K | -3.5M | 1.89M | -1.11M | -1.03M | -75.59M | 333K | 279K |
| Other Non-Cash Items | 10.18M | 7.16M | 7.31M | -14.75M | 790K | 12.1M | 17.77M | -959K | -4.43M | 79.77M | 29.7M | 2.18M |
| Working Capital Changes | -9.14M | 7.88M | 1.5M | -4.54M | 2.93M | 5.79M | 155K | -7.34M | -26M | -12.11M | 45.58M | 6.24M |
| Change in Receivables | 2.5M | 393K | 2.49M | -1.71M | 3.99M | 7.46M | 2.85M | 4.62M | 5.88M | 6.85M | 6.14M | -4.93M |
| Change in Inventory | -136K | 4.68M | 2.02M | 5.33M | 3.76M | -3.03M | 29.28M | 4.51M | -11.08M | -26.04M | 6.03M | 13.17M |
| Change in Payables | -9.6M | 0 | 0 | -3.99M | -5.73M | -4.28M | -815K | -17.9M | -20.79M | -34.34M | 40.88M | 12.32M |
| Cash from Investing | -1.65M | -1.38M | -1.08M | -1.55M | -1.15M | -862K | -2.09M | -2.04M | -1.8M | -2.17M | -4.44M | -3.22M |
| Capital Expenditures | 0 | -139K | -27K | 45K | -45K | -74K | 3.84M | -334K | -1.8M | -2.17M | -174K | -3.22M |
| CapEx % of Revenue | 0.35% | 0.17% | 0.04% | 0.06% | 0.06% | 0.09% | 4.87% | 0.37% | 2.21% | 2.24% | 0.18% | 2.74% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.46M | -1.54M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.65M | -1.24M | -1.06M | -1.6M | -1.1M | -788K | -5.93M | -1.7M | 0 | -18.46M | -2.72M | 0 |
| Cash from Financing | -20.9M | -512K | -803K | -173.36M | -250K | -770K | -204K | -98.75M | -58.62M | -31.36M | -2.35M | -1.55M |
| Debt Issued (Net) | -20.16M | -85K | -616K | -410.95M | 0 | 156.08M | 0 | -98.33M | -57.75M | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | -187K | -708K | -250K | 154.13M | -204K | -98.33M | -57.75M | -30.16M | 0 | -2.24M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -187K | -708K | -250K | 156.08M | -204K | -98.33M | -57.75M | -30.16M | 0 | -2.24M |
| Other Financing | -739K | -427K | 0 | 238.3M | 0 | -310.98M | 0 | 97.92M | 56.88M | -1.2M | -2.35M | 694K |
| Net Change in Cash | -28.3M | 13.28M | 7.4M | -161.03M | 2.97M | 11.17M | 9.35M | -95.09M | -78.39M | -36.42M | 9.72M | 17.45M |
| Free Cash Flow | -5.78M | 13.81M | 9.62M | 10.79M | 1.85M | 15.61M | 8.22M | 4.16M | -18.66M | -7.34M | 15.07M | 20.66M |
| FCF Margin % | -8.9% | 16.77% | 13.62% | 13.8% | 2.66% | 18.7% | 10.44% | 4.6% | -22.92% | -7.58% | 15.47% | 17.59% |
| FCF Growth % | -412.16% | -11.51% | 16.99% | 159.21% | 109.92% | 312.73% | -45.44% | -79.85% | -4.93% | 10.7% | 138.5% | 159.48% |
| FCF per Share | -0.04 | 0.11 | 0.08 | 0.08 | 0.01 | 0.13 | 0.07 | 0.03 | -0.13 | -0.06 | 0.11 | 0.16 |
| FCF Conversion (FCF/Net Income) | 0.84x | -1.88x | -0.87x | 0.49x | -0.30x | -1.59x | -0.56x | 30.70x | 24.82x | 0.55x | -0.24x | 6.53x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |